94 related articles for article (PubMed ID: 8126914)
21. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus DNA and p53 status in penile carcinomas.
Levi JE; Rahal P; Sarkis AS; Villa L
Int J Cancer; 1998 Jun; 76(6):779-83. PubMed ID: 9626339
[TBL] [Abstract][Full Text] [Related]
23. Detection of human papillomavirus DNA, p53 and ki67 expression in penile carcinomas.
Gentile V; Vicini P; Giacomelli L; Cardillo MR; Pierangeli A; Degener AM
Int J Immunopathol Pharmacol; 2006; 19(1):209-15. PubMed ID: 16569359
[TBL] [Abstract][Full Text] [Related]
24. Incidence of human papillomavirus 16 and 18 infection and p53 mutation in patients with oral squamous cell carcinoma in Japan.
Shima K; Kobayashi I; Saito I; Kiyoshima T; Matsuo K; Ozeki S; Ohishi M; Sakai H
Br J Oral Maxillofac Surg; 2000 Oct; 38(5):445-50. PubMed ID: 11010772
[TBL] [Abstract][Full Text] [Related]
25. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53.
Rady PL; Schnadig VJ; Weiss RL; Hughes TK; Tyring SK
Laryngoscope; 1998 May; 108(5):735-40. PubMed ID: 9591556
[TBL] [Abstract][Full Text] [Related]
26. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
Ferguson AW; Svoboda-Newman SM; Frank TS
Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
Bezerra AL; Lopes A; Santiago GH; Ribeiro KC; Latorre MR; Villa LL
Cancer; 2001 Jun; 91(12):2315-21. PubMed ID: 11413520
[TBL] [Abstract][Full Text] [Related]
28. p53 mutations and presence of HPV DNA do not correlate with radiosensitivity of gynecological cancer cell lines.
Rantanen V; Grénman S; Kurvinen K; Hietanen S; Raitanen M; Syrjänen S
Gynecol Oncol; 1998 Dec; 71(3):352-8. PubMed ID: 9887230
[TBL] [Abstract][Full Text] [Related]
29. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
30. [Human papillomavirus infection and p53 gene mutation in primary lung cancer].
Da J; Chen L; Hu Y
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):27-9. PubMed ID: 8732107
[TBL] [Abstract][Full Text] [Related]
31. High-risk human papillomavirus (HPV) is not associated with p53 and bcl-2 expression in oral squamous cell carcinomas.
Oliveira MC; Soares RC; Pinto LP; Souza LB; Medeiros SR; Costa Ade L
Auris Nasus Larynx; 2009 Aug; 36(4):450-6. PubMed ID: 19124208
[TBL] [Abstract][Full Text] [Related]
32. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay.
Kashiwazaki H; Tonoki H; Tada M; Chiba I; Shindoh M; Totsuka Y; Iggo R; Moriuchi T
Oncogene; 1997 Nov; 15(22):2667-74. PubMed ID: 9400993
[TBL] [Abstract][Full Text] [Related]
33. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.
Saranath D; Tandle AT; Teni TR; Dedhia PM; Borges AM; Parikh D; Sanghavi V; Mehta AR
Oral Oncol; 1999 May; 35(3):242-50. PubMed ID: 10621843
[TBL] [Abstract][Full Text] [Related]
34. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions.
Tervahauta AI; Syrjänen SM; Väyrynen M; Saastamoinen J; Syrjänen KJ
Anticancer Res; 1993; 13(4):1107-11. PubMed ID: 8394670
[TBL] [Abstract][Full Text] [Related]
35. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer.
Moonen PM; Bakkers JM; Kiemeney LA; Schalken JA; Melchers WJ; Witjes JA
Eur Urol; 2007 Aug; 52(2):464-8. PubMed ID: 17116360
[TBL] [Abstract][Full Text] [Related]
36. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of human papilloma virus DNA in head and neck cancers carrying wild-type or mutant p53 tumor suppressor genes.
Adams V; Schmid S; Zariwala M; Schmid M; Kleihues P; Briner J; Schäfer R
Anticancer Res; 1999; 19(1A):1-6. PubMed ID: 10226517
[TBL] [Abstract][Full Text] [Related]
38. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR
Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227
[TBL] [Abstract][Full Text] [Related]
39. Carcinoma of the vulva: HPV and p53 mutations.
Lee YY; Wilczynski SP; Chumakov A; Chih D; Koeffler HP
Oncogene; 1994 Jun; 9(6):1655-9. PubMed ID: 8183560
[TBL] [Abstract][Full Text] [Related]
40. Detection of p53 point mutations in primary human vulvar cancer by PCR and temperature gradient gel electrophoresis.
Sliutz G; Schmidt W; Tempfer C; Speiser P; Gitsch G; Eder S; Schneeberger C; Kainz C; Zeillinger R
Gynecol Oncol; 1997 Jan; 64(1):93-8. PubMed ID: 8995554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
